139 related articles for article (PubMed ID: 31009154)
1. Reactivity of platelet-activating and nonplatelet-activating anti-PF4/heparin antibodies in enzyme immunosorbent assays under different conditions.
Nguyen TH; Wesche J; Raschke R; Strobel U; Bui VC; Delcea M; Greinacher A
J Thromb Haemost; 2019 Jul; 17(7):1113-1119. PubMed ID: 31009154
[TBL] [Abstract][Full Text] [Related]
2. Effect of pH and ionic strength on the binding strength of anti-PF4/polyanion antibodies.
Nguyen TH; Greinacher A
Eur Biophys J; 2017 Dec; 46(8):795-801. PubMed ID: 28712066
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical Characteristics of Platelet Factor 4 under Various Conditions are Relevant for Heparin-Induced Thrombocytopenia Testing.
Bui VC; Gebicka P; Hippe H; Raschke R; Nguyen TL; Greinacher A; Nguyen TH
J Phys Chem B; 2020 Feb; 124(8):1438-1443. PubMed ID: 31944769
[TBL] [Abstract][Full Text] [Related]
5. Distinct Binding Characteristics of Pathogenic Anti-Platelet Factor-4/Polyanion Antibodies to Antigens Coated on Different Substrates: A Perspective on Clinical Application.
Nguyen TH; Greinacher A
ACS Nano; 2018 Dec; 12(12):12030-12041. PubMed ID: 30540167
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.
Greinacher A; Juhl D; Strobel U; Wessel A; Lubenow N; Selleng K; Eichler P; Warkentin TE
J Thromb Haemost; 2007 Aug; 5(8):1666-73. PubMed ID: 17488345
[TBL] [Abstract][Full Text] [Related]
8. Combined use of the high heparin step and optical density to optimize diagnostic sensitivity and specificity of an anti-PF4/heparin enzyme-immunoassay.
Althaus K; Strobel U; Warkentin TE; Greinacher A
Thromb Res; 2011 Sep; 128(3):256-60. PubMed ID: 21620439
[TBL] [Abstract][Full Text] [Related]
9. Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium.
Pouplard C; Amiral J; Borg JY; Vissac AM; Delahousse B; Gruel Y
Br J Haematol; 1997 Nov; 99(2):273-80. PubMed ID: 9375738
[TBL] [Abstract][Full Text] [Related]
10. Characterization of New Monoclonal PF4-Specific Antibodies as Useful Tools for Studies on Typical and Autoimmune Heparin-Induced Thrombocytopenia.
Vayne C; Nguyen TH; Rollin J; Charuel N; Poupon A; Pouplard C; Normann N; Gruel Y; Greinacher A
Thromb Haemost; 2021 Mar; 121(3):322-331. PubMed ID: 33086397
[TBL] [Abstract][Full Text] [Related]
11. 5B9, a monoclonal antiplatelet factor 4/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies.
Kizlik-Masson C; Vayne C; McKenzie SE; Poupon A; Zhou Y; Champier G; Pouplard C; Gruel Y; Rollin J
J Thromb Haemost; 2017 Oct; 15(10):2065-2075. PubMed ID: 28771917
[TBL] [Abstract][Full Text] [Related]
12. Characterization of platelet factor 4 amino acids that bind pathogenic antibodies in heparin-induced thrombocytopenia.
Huynh A; Arnold DM; Kelton JG; Smith JW; Horsewood P; Clare R; Guarné A; Nazy I
J Thromb Haemost; 2019 Feb; 17(2):389-399. PubMed ID: 30582672
[TBL] [Abstract][Full Text] [Related]
13. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.
Schenk S; El-Banayosy A; Morshuis M; Arusoglu L; Eichler P; Lubenow N; Tenderich G; Koerfer R; Greinacher A; Prohaska W
J Thromb Haemost; 2007 Feb; 5(2):235-41. PubMed ID: 17083649
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation.
Amiral J; Pouplard C; Vissac AM; Walenga JM; Jeske W; Gruel Y
Br J Haematol; 2000 May; 109(2):336-41. PubMed ID: 10848821
[TBL] [Abstract][Full Text] [Related]
15. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
Visentin GP; Ford SE; Scott JP; Aster RH
J Clin Invest; 1994 Jan; 93(1):81-8. PubMed ID: 8282825
[TBL] [Abstract][Full Text] [Related]
16. Use of a whole-cell ELISA to detect additional antibodies in setting of suspected heparin-induced thrombocytopenia.
Bashover EM; Stefaniuk CM; Harding CV; Maitta RW
Eur J Haematol; 2019 Aug; 103(2):99-106. PubMed ID: 31107976
[TBL] [Abstract][Full Text] [Related]
17. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia: towards standardization of platelet factor 4/heparin antigen tests.
Greinacher A; Ittermann T; Bagemühl J; Althaus K; Fürll B; Selleng S; Lubenow N; Schellong S; Sheppard JI; Warkentin TE
J Thromb Haemost; 2010 Sep; 8(9):2025-31. PubMed ID: 20626620
[TBL] [Abstract][Full Text] [Related]
19. New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia.
Gobbi G; Mirandola P; Tazzari PL; Talarico E; Caimi L; Martini G; Papa S; Conte R; Manzoli FA; Vitale M
Cytometry B Clin Cytom; 2004 Mar; 58(1):32-8. PubMed ID: 14994373
[TBL] [Abstract][Full Text] [Related]
20. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
